PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP)

Historical Holders from Q3 2020 to Q3 2025

Symbol
PMVP on Nasdaq
Type / Class
Equity / Common stock, par value $0.00001 per share
Shares outstanding
52,942,731
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
37,492,718
Holdings value
$52,488,395
% of all portfolios
0%
Number of holders
63
Number of buys
31
Number of sells
-27
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORBIMED ADVISORS LLC 9.4% $6,965,407 4,975,291 ORBIMED ADVISORS LLC 23 Oct 2025
TANG CAPITAL MANAGEMENT LLC 8.9% $6,702,907 4,720,357 TANG CAPITAL MANAGEMENT, LLC 16 Sep 2025
BML Investment Partners, L.P. 6.7% $3,744,019 3,466,684 BML Investment Partners, L.P. 31 Dec 2024
Sio Capital Management, LLC 4.98% -32% $3,691,167 -$1,538,387 2,636,548 -29% Sio Capital Management, LLC 30 Sep 2025

Institutional Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 37,492,718 $52,488,395 +$4,772,987 $1.4 63
2025 Q2 34,680,709 $36,758,763 -$2,911,770 $1.06 52
2025 Q1 37,320,031 $40,676,123 -$2,281,115 $1.09 54
2024 Q4 38,959,310 $58,833,270 -$767,790 $1.51 70
2024 Q3 39,023,873 $58,153,846 -$2,416,795 $1.49 73
2024 Q2 40,492,185 $65,594,864 -$3,771,661 $1.62 91
2024 Q1 42,725,320 $72,627,924 -$11,853,919 $1.7 96
2023 Q4 46,465,983 $144,025,863 -$52,160,467 $3.1 97
2023 Q3 54,236,025 $333,006,052 +$15,386,619 $6.14 103
2023 Q2 51,696,984 $323,689,509 +$3,281,155 $6.26 104
2023 Q1 51,513,177 $245,718,220 -$16,150,590 $4.77 111
2022 Q4 54,555,170 $474,625,571 -$38,255,414 $8.7 113
2022 Q3 58,187,852 $692,436,457 -$36,596,424 $11.9 116
2022 Q2 61,123,657 $870,921,498 +$53,476,878 $14.25 105
2022 Q1 55,249,345 $1,150,065,944 +$162,099,243 $20.82 98
2021 Q4 47,470,437 $1,096,597,184 +$15,190,740 $23.1 102
2021 Q3 43,990,444 $1,310,907,931 +$46,789,977 $29.8 91
2021 Q2 42,241,228 $1,442,956,792 +$80,038,413 $34.16 83
2021 Q1 39,915,363 $1,312,819,295 +$51,865,975 $32.89 81
2020 Q4 38,212,089 $2,335,342,669 +$185,049,476 $61.51 72
2020 Q3 31,212,908 $1,098,804,001 +$1,098,804,001 $35.5 51